Exosomes as the source of biomarkers of metabolic diseases

키워드

참고문헌 (58)

1. Guescini M, "C2C12 myoblasts release microvesicles containing mtDNA and proteins involved in signal transduction", Exp Cell Res, 316, pp.1977~1984 (2010)
2. Aoki N, "Identification and characterization of microvesicles secreted by 3T3-L1 adipocytes: redox- and hormonedependent induction of milk fat globule-epidermal growth factor 8-associated microvesicles", Endocrinology, 148, pp.3850~3862 (2007)
3. Conde-Vancells J, "Characterization and comprehensive proteome profiling of exosomes secreted by hepatocytes.", J Proteome Res, 7, pp.5157~5166 (2008)
4. R aiborg C, "The ESCRT machiner y in endosomal sorting of ubiquitylated membrane proteins", Nature, 458, pp.445~452 (2009)
5. Baietti MF, "Syndecan-syntenin-ALIX regulates the biogenesis of exosomes", Nat Cell Biol, 14, pp.677~685 (2012)
6. Villarroya-Beltri C, "Sorting it out: regulation of exosome loading", Semin Cancer Biol, 28, pp.3~13 (2014)
7. EL Andaloussi S, "Extracellular vesicles: biology and emerging therapeutic opportunities", Nat Rev Drug Discov, 12, pp.347~357 (2013)
8. Simhadri VR, "Dendritic cells release HLA-Bassociated transcript-3 positive exosomes to regulate natural killer function", PLoS One, 3, pp.e3377~ (2008)
9. Chivet M, "Emerging role of neuronal exosomes in the central nervous system", Front Physiol, 3, pp.145~ (2012)
10. Jang YY, "Hematopoietic stem cells convert into liver cells within days without fusion", Nat Cell Biol, 6, pp.532~539 (2004)
11. Quesenberry PJ, "Cellular phenotype switching and microvesicles", Adv Drug Deliv Rev, 62, pp.1141~1148 (2010)
12. Lai RC, "Mesenchymal stem cell exosome:a novel stem cell-based therapy for cardiovascular disease", Regen Med, 6, pp.481~492 (2011)
13. Timmers L, "Human mesenchymal stem cellconditioned medium improves cardiac function following myocardial infarction", Stem Cell Res, 6, pp.206~214 (2011)
14. Camussi G, "Exosome", microvesicle-mediated epigenetic reprogramming of cells, 2011, pp.1, 98~110
15. Rak J, "Extracellular vesicles: vehicles that spread cancer genes", Bioessays, 34, pp.489~497 (2012)
16. Cai Z, "Activated T cell exosomes promote tumor invasion via Fas signaling pathway", J Immunol, 188, pp.5954~5961 (2012)
17. Bellingham SA, "Exosomes:vehicles for the transfer of toxic proteins associated with neurodegenerative diseases?", Front Physiol, 3, pp.124~ (2012)
18. Emmanouilidou E, "Cell-produced alphasynuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival", J Neurosci, 30, pp.6838~6851 (2010)
19. Aswad H, "Exosomes participate in the alteration of muscle homeostasis during lipid-induced insulin resistance in mice", Diabetologia, 57, pp.2155~2164 (2014)
20. Jayachandran M, "Alterations in platelet function and cell-derived microvesicles in recently menopausal women:relationship to metabolic syndrome and atherogenic risk", J Cardiovasc Transl Res, 4, pp.811~822 (2011)
21. Diamant M, "Elevated numbers of tissue-factor exposing microparticles correlate with components of the metabolic syndrome in uncomplicated type 2 diabetes mellitus", Circulation, 106, pp.2442~2447 (2002)
22. D'Alessandra Y, "Circulating microRNAs are new and sensitive biomarkers of myocardial infarction", Eur Heart J, 31, pp.2765~2773 (2010)
23. Feng B, "Circulating level of microparticles and their correlation with arterial elasticity and endothelium-dependent dilation in patients with type 2 diabetes mellitus", Atherosclerosis, 208, pp.264~269 (2010)
24. Kim SJ, "Circulating mesenchymal stem cells microparticles in patients with cerebrovascular disease", PLoS One, 7, pp.e37036~ (2012)
25. Ogata M, "Ca(2+)-dependent and caspase-3-independent apoptosis caused by damage in Golgi apparatus due to 2,4,5,7-tetrabromorhodamine 123bromide-induced photodynamic effects", Photochem Photobiol, 78, pp.241~247 (2003)
26. Safdar A, "The potential of endurance exercise-derived exosomes to treat metabolic diseases", Nat Rev Endocrinol, 12, pp.504~517 (2016)
27. Jalabert A, "Exosome-like vesicles released from lipid-induced insulin-resistant muscles modulate gene expression and proliferation of beta recipient cells in mice", Diabetologia, 59, pp.1049~1058 (2016)
28. Lee JE, "Proteomic analysis of extracellular vesicles released by adipocytes of Otsuka Long-Evans Tokushima Fatty (OLETF) Rats", Protein J, 34, pp.220~235 (2015)
29. Santovito D, "Plasma exosome microRNA profiling unravels a new potential modulator of adiponectin pathway in diabetes: effect of glycemic control", J Clin Endocrinol Metab, 99, pp.E1681~E1685 (2014)
30. Deng ZB, "Adipose tissue exosome-like vesicles mediate activation of macrophage-induced insulin resistance", Diabetes, 58, pp.2498~2505 (2009)
31. Jansen F, "Endothelial microparticle-mediated transfer of MicroRNA-126 promotes vascular endothelial cell repair via SPRED1 and is abrogated in glucosed amaged endotheli al micropar ticles", Circulation, 128, pp.2026~2038 (2013)
32. Wang X, "Cardiomyocytes mediate anti-angiogenesis in type 2diabetic rats through the exosomal transfer of miR-320 into endothelial cells", J Mol Cell Cardiol, 74, pp.139~150 (2014)
33. O'Neill S, "Blood-based biomarkers for metabolic syndrome", Trends Endocrinol Metab, 27, pp.363~374 (2016)
34. Biomarkers Definitions Working Group, "Biomarkers and surrogate endpoints: preferred definitions and conceptual framework", Clin Pharmacol Ther, 69, pp.89~95 (2001)
35. Lawson C, "Microvesicles and exosomes: new players in metabolic and cardiovascular disease", J Endocrinol, 228, pp.R57~R71 (2016)
36. Koeck ES, "Adipocyte exosomes induce transforming growth factor beta pathway dysregulation in hepatocytes: a novel paradigm for obesity-related liver disease", J Surg Res, 192, pp.268~275 (2014)
37. Nicklas BJ, "Association of visceral adipose tissue with incident myocardial infarction in older men and women: the Health, Aging and Body Composition Study", Am J Epidemiol, 160, pp.741~749 (2004)
38. Kanhai DA, "The risk of general and abdominal adiposity in the occurrence of new vascular events and mortality in patients with various manifestations of vascular disease", Int J Obes (Lond), 36, pp.695~702 (2012)
39. Livshits MA, "Corrigendum: Isolation of exosomes by differential centrifugation: Theoretical analysis of a commonly used protocol", Sci Rep, 6, pp.21447~ (2016)
40. Cocucci E, "Enlargeosome traffic: exocytosis triggered by various signals is followed by endocytosis, membrane shedding or both", Traffic, 8, pp.742~757 (2007)
41. Eken C, "Polymorphonuclear neutrophil-derived ectosomes interfere with the maturation of monocytederived dendritic cells", J Immunol, 180, pp.817~824 (2008)
42. Lötvall J, "Minimal experimental requirements for definition of extracellular vesicles and their functions:a position statement from the International Society for Extracellular Vesicles", J Extracell Vesicles, 3, pp.26913~ (2014)
43. Linares R, "Highspeed centrifugation induces aggregation of extracellular vesicles", J Extracell Vesicles, 4, pp.29509~ (2015)
44. Van Deun J, "The impact of disparate isolation methods for extracellular vesicles on downstream RNA profiling", J Extracell Vesicles, 3, pp.24858~ (2014)
45. Kalra H, "Comparative proteomics evaluation of plasma exosome isolation techniques and assessment of the stability of exosomes in normal human blood plasma", Proteomics, 13, pp.3354~3364 (2013)
46. Hong CS, "Isolation of biologically active and morphologically intact exosomes from plasma of patients with cancer", J Extracell Vesicles, 5, pp.29289~ (2016)
47. Fiandaca MS, "Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case-control study", Alzheimers Dement, 11, pp.600~607 (2015)
48. Shi M, "Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson's disease", Acta Neuropathol, 128, pp.639~650 (2014)
49. Lobb RJ, "Leimgruber A, et al. Optimized exosome isolation protocol for cell culture supernatant and human plasma", J Extracell Vesicles, 4, pp.27031~ (2015)
50. Agouni A, "Microparticles from patients with metabolic syndrome induce vascular hypo-reactivity via Fas", Fasligand pathway in mice, 2011, pp.6, e27809~
51. Agouni A, "Endothelial dysfunction caused by circulating microparticles from patients with metabolic syndrome", Am J Pathol, 173, pp.1210~1219 (2008)
52. Amabile N, "Association of circulating endothelial microparticles with cardiometabolic risk factors in the Framingham Heart Study", Eur Heart J, 35, pp.2972~2979 (2014)
53. Chen Y, "Plasma endothelial microparticles and their correlation with the presence of hypertension and arterial stiffness in patients with type 2diabetes", J Clin Hypertens (Greenwich), 14, pp.455~460 (2012)
54. Kranendonk ME, "Extracellular vesicle markers in relation to obesity and metabolic complications in patients with manifest cardiovascular disease", Cardiovasc Diabetol, 13, pp.37~ (2014)
55. Burger D, "Urinary podocyte microparticles identify prealbuminuric diabetic glomerular injury", J Am Soc Nephrol, 25, pp.1401~1407 (2014)
56. Sun AL, "Dipeptidyl peptidase-IV is a potential molecular biomarker in diabetic kidney disease", Diab Vasc Dis Res, 9, pp.301~308 (2012)
57. Zubiri I, "Diabetic nephropathy induces changes in the proteome of human urinary exosomes as revealed by label-free comparative analysis", J Proteomics, 96, pp.92~102 (2014)
58. Witwer KW, "Standardization of sample collection, isolation and analysis methods in extracellular vesicle research", J Extracell Vesicles, 2, pp.20360~ (2013)